GlassScriptPhysician profile
Stephen Lazaroff
NPI 1588084362
$3,424.44
in general payments reported to CMS, 2019-2025
13 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $925 · 2020: $579 · 2021: $330 · 2022: $270 · 2023: $914 · 2024: $84.64 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gramercy Extremity Orthopedics LLC | $1,209.56 | 2019-2023 | |
| Smith+Nephew, INC. | $855.10 | 2019-2025 | Grafix Pl, Stravix, Peri-Loc |
| Celularity INC. | $259.00 | 2019 | |
| Organogenesis INC. | $185.00 | 2025 | Apligraf, Simplimax, Cygnus Matrix |
| Orthofix Medical, INC. | $177.50 | 2019-2023 | Truelok System, Trinity Elite, Truelok |
| Gotham Surgical Solutions & Devices, INC. | $144.27 | 2020 | |
| Osiris Therapeutics INC. | $119.38 | 2019 | |
| Bone Support INC. | $112.50 | 2025 | Ceramentbone Void Filler, Cerament G |
| Acera Surgical, INC. | $91.86 | 2022 | |
| Stryker Corporation | $79.38 | 2020-2024 | Viaflow |
| Nuo Therapeutics | $66.64 | 2024 | |
| Fidia Pharma USA INC. | $65.36 | 2019 | |
| Hydrofera LLC | $58.89 | 2023 | Cutimed Sorbact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$400,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lazaroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.